Fierce Biotech Week 2025
Event summary
Cooley is a proud sponsor of Fierce Biotech Week, which brings together the brightest minds in drug development, clinical research, business development and licensing, Trial Master File (TMF) management and communications to advance innovation and shape biotech’s future. Get ready to spark new partnerships, accelerate breakthroughs and lead in this dynamic and rapidly evolving industry.
Featured agenda item
Tuesday, October 7, 2025 | 2:30 – 3:15 pm (EDT)
Anatomy of the Biotech IPO: Legal and Strategic Lessons
Cooley partner Richard Segal is speaking on this panel.
Whether you're a biotech founder, a business development lead or a strategic investor, this session will offer actionable guidance on timing, readiness and long-term positioning.
- Understand the legal and structural foundations biotech companies must have in place before even considering going public.
- Explore how market conditions, investor expectations and deal momentum influence initial public offering (IPO) timing and valuation.
- Learn how public market readiness affects partnership conversations with pharma, VCs and strategic acquirers.
- Examine case studies on what separates smooth IPOs from those that stall or backfire post-listing.
For more information, please email Andrew Gentilucci.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.